ABC | Volume 111, Nº5, November 2018

Review Article Silva et al miRNAs and cardiovascular disease Arq Bras Cardiol. 2018; 111(5):738-746 1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843-54. 2. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15(spec1):R17-29. 3. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature . 2004;432(7014):226-30. 4. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regionsinvolvedincancers.ProcNatlAcadSciUSA.2004;101(9):2999-3004. 5. Zhou X, Zuo Z, Zhou F, Zhao W, Sakaguchi Y, Suzuki T, et al. Profiling sex- specific piRNAs in zebrafish. Genetics . 2010;186(4):1175-85. 6. Chang TC, Mendell JT. MicroRNAs in vertebrate physiology and human disease. Annu Rev Genomics HumGenet . 2007;8:215-39. 7. Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 2004;5(5):396-400. 8. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol . 2005;6(5):376-85. 9. Han J, Lee Y, YeomKH, Nam JW, Heo I, Rhee JK, et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell . 2006;125(5):887-901. 10. Lee Y, Han J, Yeom KH, Jin H, Kim VN. Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol. 2006;71:51-7. 11. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev . 2003;17(24):3011-6. 12. KimVN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat RevMol Cell Biol. 2009;10(2):126-39. 13. Krützfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet. 2006;38 ( Suppl):S14-9. 14. Rand TA, Petersen S, Du F,Wang X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell. 2005;123(4):621-9. 15. Tang G, Reinhart BJ, Bartel DP, Zamore PD. A biochemical framework for RNA silencing in plants. Genes Dev. 2003;17(1):49-63. 16. Zeng Y, Wagner EJ, Cullen BR. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell. 2002;9(6):1327-33. 17. Gebauer F, HentzeMW. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol. 2004;5(10):827-35. 18. Zhang J, Zhao H, Gao Y, Zhang W. Secretory miRNAs as novel cancer biomarkers. Biochim Biophys Acta. 2012;1826(1):32-43. 19. MuoioDM, Newgard CB. Mechanisms of disease: molecular andmetabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(3):193-205. 20. van Rooij E, Liu N, Olson EN. MicroRNAs flex their muscles. Trends Genet. 2008;24(4):159-66. 21. WangJ,HuangW,XuR,NieY,CaoX,MengJ,etal.MicroRNA-24regulatescardiac fibrosisaftermyocardial infarction.JCellMolMed.2012;16(9):2150-60. 22. Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond). 2010;119(2):87-95. 23. Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res. 2009;105(6):585-94. 24. Xin Y,Yang C, Han Z. Circulating miR-499 as a potential biomarker for acute myocardial infarction. Ann Transl Med. 2016;v.4. 25. Xiao J, Shen B, Li J, Lv D, Zhao Y, Wang F, et al. Serum microRNA-499 and microRNA-208a as biomarkers of acutemyocardial infarction. Int J Clin Exp Med. 2014;7(1):136-41 26. Chen X, Zhang L, Su T, Li H, Huang Q, Wu D, et al. Kinetics of plasma microRNA-499 expression in acute myocardial infarction. J Thorac Dis. 2015;7(5):890-6. 27. Bye A, Røsjø H, Nauman J, Silva GJ, Follestad T, Omland T, et al. Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - The HUNT study. J Mol Cell Cardiol. 2016 Aug;97:162-8. 28. Jia K, Shi P, Han X, Chen T, Tang H, Wang J. Diagnostic value of miR-30d- 5p and miR-125b-5p in acute myocardial infarction. Mol Med Rep. 2016;14(1):184-94. 29. Yan H, Ma F, Zhang Y, Wang C, Qiu D, Zhou K, et al. miRNAs as biomarkers for diagnosis of heart failure: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(22):e6825. 30. Cakmak HA, Coskunpinar E, Ikitimur B, BarmanHA, Karadag B, Tiryakioglu NO. The prognostic value of circulating microRNAs in heart failure: preliminary results froma genome-wide expression study. J CardiovascMed (Hagerstown). 2015;16(6):431-7. 31. Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016;18(5):457-68. 32. Lakschevitz F, Aboodi G, Tenenbaum H, Glogauer M. Diabetes and periodontaldiseases: interplayand links.CurrDiabetesRev.2011;7(6):433-9. 33. Harling L, Lambert J, Ashrafian H, Darzi A, Gooderham NJ, Athanasiou T. Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation. Eur J Cardiothorac Surg. 2017;51(1):73-8. 34. Feldman A, MoreiraDA, GunC,WangHL, HirataMH, de Freitas Germano J, et al. Analysis of circulatingmiR-1, miR-23a, andmiR-26a in atrial fibrillation patients undergoing coronary bypass artery grafting surgery. Ann Hum Genet. 2017;81(3):99-105. 35. Wei XJ, Han M, Yang FY, Wei GC, Liang ZG, Yao H, et al. Biological significance of miR-126 expression in atrial fibrillation and heart failure. Braz J Med Biol Res. 2015;48(11):983-9. 36. GorenY,MeiriE,HoganC,MitchellH,LebanonyD,SalmanN,etal.Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure. Am J Cardiol. 2014;113(6):976-81. 37. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, et al. DeliveryofmicroRNA-126byapoptoticbodies inducesCXCL12-dependent vascular protection. Sci Signal. 2009;2(100): 81. 38. Jeong HS, Kim JY, Lee SH, Hwang J, Shin JW, Song KS, et al. Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence. PLoS One. 2017;12(5):e0177809. 39. Liu CZ, ZhongQ, Huang YQ. Elevated plasmaMiR-29a levels are associated with increased carotid intima-media thickness in atherosclerosis patients. Tohoku J Exp Med. 2017;241(3):183-8. 40. Piubelli C, Meraviglia V, Pompilio G, D’Alessandra Y, Colombo GI, Rossini A. microRNAs and Cardiac Cell Fate. Cells. 2014;3(3):802-23 41. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle- specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005;436(7048):214-20. 42. Carmean CM, Bobe AM, Yu JC, Volden PA, Brady MJ. Refeeding-induced brown adipose tissue glycogen hyper-accumulation in mice is mediated by insulin and catecholamines. PLoS One. 2013;8(7):e67807. References 744